KIDRON NADAV has filed 15 insider transactions across 2 companies since January 2024.
Most recent transaction: a tax payment of 44818 shares of ORAMED PHARMACEUTICALS INC. ($ORMP) on March 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | F | Common Stock | 44818 | $3.31 | 3,548,243.0000 | 42,418,644 | 1.25% | 0.11% |
| March 25, 2026 | Lifeward Ltd. | $LFWD | KIDRON NADAV | Director | A | Ordinary Shares, no par value per share | 7657 | $0.00 | 7,657.0000 | 17,732,137 | 9999.99% | 0.04% |
| March 17, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 167005 | $0.00 | 3,422,243.0000 | 42,774,504 | 5.13% | 0.39% |
| March 12, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | G | Common Stock | 100000 | $0.00 | 3,255,238.0000 | 42,774,504 | 2.98% | 0.23% |
| Jan. 22, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | M | Common Stock | 109000 | $0.00 | 3,355,238.0000 | 42,774,504 | 3.36% | 0.25% |
| Jan. 22, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | M | Performance Stock Units | 109000 | $0.00 | 0.0000 | 42,774,504 | 100.00% | 0.25% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 327000 | $0.00 | 3,372,238.0000 | 42,774,504 | 10.74% | 0.76% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Performance Stock Units | 109000 | $0.00 | 109,000.0000 | 42,774,504 | 9999.99% | 0.25% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 232640 | $0.00 | 3,045,238.0000 | 42,774,504 | 8.27% | 0.54% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 186000 | $0.00 | 2,712,598.0000 | 40,828,380 | 7.36% | 0.46% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 141000 | $0.00 | 2,526,598.0000 | 40,828,380 | 5.91% | 0.35% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 100000 | $0.00 | 2,812,598.0000 | 40,828,380 | 3.69% | 0.24% |
| Jan. 2, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 433500 | $0.00 | 2,385,598.0000 | 40,828,380 | 22.21% | 1.06% |
| Nov. 7, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 45000 | $0.00 | 1,952,098.0000 | 40,896,845 | 2.36% | 0.11% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | KIDRON NADAV | President and CEO | A | Common Stock | 329000 | $0.00 | 1,907,098.0000 | 40,566,901 | 20.85% | 0.81% |